Journal of Thoracic Oncology

Edit Your Profile

Journal of Thoracic Oncology Journal

publication venue for

EP.08.19 Timing and Predictors of Lymphopenia in Lung Cancer Patients Undergoing Proton and Photon Chemoradiotherapy. 20:s756. 2025
P2.06.76 Molecular Profiling of Lung Cancer Brain Metastases: Analysis Between Liquid Biopsy and Brain Metastasis Tissue Results. 20:s326-s327. 2025
P2.03-04 Predicting Risk of Distant Brain Failure with Radiosurgery and Systemic Therapy in a Diverse NSCLC Brain Metastasis Population. 18:s303. 2023
EP07.03-006 Feasibility of TTFields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Real-World Data. 17:s332-s333. 2022
P19.06 Radiosurgery followed by Tumor Treating Fields for brain metastases (1-10) from NSCLC in the phase 3 METIS trial. 16:s357. 2021
3PD Liquid biopsy in patients with adenocarcinoma of the lung and its correlation with their tumor tissue molecular profile. 11:S58. 2016
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum-and erlotinib-resistant adenocarcinoma of the lung. 5:1054-1059. 2010
Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer. 5:533-539. 2010
Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer. 3:511-515. 2008
P3-197: Risk of central nervous system bleeding in patients with brain metastases from non–small cell lung cancer (NSCLC) following whole brain radiation therapy (wbrt) is low. 2:s764. 2007
Feasibility of TTFields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Real-World Data 2022
Genomic Evolution During TKI Treatment in Non-Small Cell Lung Cancer Patients With or Without Acquired T790M Mutation 2019
Tumor Treating Fields and Radiosurgery for Supra-and/or Infratentorial Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Study 2018
Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression 2017
METIS: A Phase 3 Study of Radiosurgery with TTFields for 1-10 Brain Metastases from NSCLC 2017
Report on Liquid Biopsies from Advanced Lung Adenocarcinoma Patients and Correlation with Their Tumor Biopsy Profiles 2017
"Real World" Use of Liquid Biopsy in Patients With Lung Adenocarcinoma and Correlation With Tumor Tissue Genetic Profile 2016
Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar 2016
Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar 2016
Genomic Analysis of Lung Cancer Tumors from Hispanic Patients Living in the US 2015
EXPLORING DISPARITIES IN HEALTH CARE OUTCOMES IN MINORITY POPULATIONS WITH SMALL (SCLC) AND NON-SMALL CELL LUNG CANCERS (NSCLC) 2013
MEMORY PRESERVATION WITH CONFORMAL AVOIDANCE OF THE HIPPOCAMPUS DURING WHOLE-BRAIN RADIOTHERAPY FOR PATIENTS WITH BRAIN METASTASES: PRELIMINARY RESULTS OF RTOG 0933 2013
PHASE I STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASES 2012
Sublobar Resection with Intraoperative 125I Brachytherapy vs Stereotactic Body Radiation Therapy for Treatment of Clinical Early Stage Non-Small Cell Lung Cancer in Patients not Eligible for Lobectomy 2012
PHASE 1 SAFETY AND PHARMACOKINETIC (PK) STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASES 2012
ADVERSE EVENTS AND PATTERNS OF TUMOR PROGRESSION IN MET DIAGNOSTIC SUBGROUPS IN OAM4558G; A PHASE II STUDY EVALUATING METMAB OR PLACEBO IN COMBINATION WITH ERLOTINIB IN ADVANCED NSCLC 2011
Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials 2007
Predictors of survival for non-small-cell lung cancer patients with brain metastases treated with whole brain radiation therapy: pooled data from two randomized trials 2007
Lung Cancer in Peru 2020
ROS-1 Rearrangements in Circulating Tumor Cells 2018
EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution? 2018
Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping 2017
Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer 2006
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC 2018
Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. 2023
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. 2022
Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial 2019
TGF-β Signaling Pathway in Lung Adenocarcinoma Invasion 2010

International Standard Serial Number (ISSN)

1556-0864

Electronic International Standard Serial Number (EISSN)

1556-1380